Filter
Top Products
26 Stratos LV/LV-T Technical Manual
Table 2: Atrial Fibrillation Demographics at Enrollment
Characteristic Group 1 Group 2 Group 3 P-value*
Rate Control
Medication,
Reasons for
Discontinuation
Ineffective
Not tolerated
Other
N=17
10 (58.8%)
8 (47.1%)
1 (5.9%)
N=20
13 (65.0%)
7 (35.0%)
2 (10.0%)
N=12
9 (75.0%)
3 (25.0%)
0 (0.0%)
0.558
0.760
0.800
Rhythm Control
Medication,
Reasons for
Discontinuation
Ineffective
Not tolerated
Other
N=22
17 (77.3%)
6 (27.3%)
1 (4.5%)
N=25
20 (80.0%)
7 (28.0%)
1 (4.0%)
N=13
8 (61.5%)
6 (46.2%)
2 (15.4%)
0.759
0.530
0.430
Cardioversion
History
Successful prior
electrical
cardioversion
Transthoracic
Transvenous
Unsuccessful prior
electrical
cardioversion
Transthoracic
Transvenous
No electrical
cardioversion
attempted
Successful prior
pharmacological
cardioversion
Unsuccessful prior
pharmacological
cardioversion
No pharmacological
cardioversion
attempted
N=42
13 (31.0%)
13 (100.0%)
0 (0.0%)
15 (35.7%)
15 (100.0%)
0 (0.0%)
17 (40.5%)
5 (11.9%)
8 (19.0%)
23 (54.8%)
N=49
16 (32.7%)
15 (93.8%)
1 (6.3%)
14 (28.6%)
14 (93.3%)
2 (13.3%)
20 (40.8%)
3 (6.1%)
11 (22.4%)
29 (59.2%)
N=25
10 (40.0%)
10 (100.0%)
0 (0.0%)
7 (28.0%)
7 (100.0%)
0 (0.0%)
9 (36.0%)
3 (12.0%)
7 (28.0%)
15 (60.0%)
0.760
0.808
0.680
0.741
0.936
0.547
0.678
0.915
*Chi-Square test (2-sided)